CALC
CalciMedica, Inc.
Biotechnology · Healthcare · United States
1.46
close · 2026-10-30
value
2
cheaper than peers2
quality
6
stronger fundamentals6
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.63× | 64 |
| earnings yield, 1 year ago | -83.6% | 26 |
| earnings yield, latest year | -134.9% | 14 |
| cash flow yield, 3 years ago | -118.0% | 10 |
| cash flow yield, 1 year ago | -212.2% | 7 |
| earnings yield, 2 years ago | -524.7% | 4 |
| cash flow yield, latest year | -212.7% | 4 |
| cash flow yield, 2 years ago | -258.9% | 4 |
8 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 0.0% | 50 |
| return on equity | -365.7% | 7 |
| debt to equity | 166.9% | 5 |
3 of 4 measures available
Facts
| market cap | $10M |
| free cash flow | — |
| employees | 16 |
| first trade | 2023-06-14 |
| next earnings | not reported |
| fundamentals updated | 2026-08-14 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -1.97 | -1.22 | -7.66 | -111.16 |
| free cash flow | -$21.2M | -$21.2M | -$25.8M | -$11.8M |
| net income | -$29.6M | -$13.7M | -$34.4M | -$7.8M |
| revenue | $0 | $0 | $0 | $0 |
| unusual items | -$6.0M | $9.5M | $3.2M | $6.5M |